GuideSurgery

30-day and 2-year survival after infrainguinal revascularisation for chronic limb-threatening ischaemia (VQI)

VQI registry models estimating survival after infrainguinal bypass or endovascular treatment for chronic limb-threatening ischaemia.

Updated 3 November 2026

When to use it

Choosing between bypass and endovascular treatment in CLTI: open surgery pays off more in those expected to survive beyond 2 years.

What it is

Cox models with preoperative variables derived from 38,470 Vascular Quality Initiative patients (2003–2017) with CLTI treated with bypass (37%) or endovascular intervention (63%). They model survival at 30 days, 2 years and 5 years.

Keep reading in the app

  • Predictors
  • Published risk categories
  • Practical use

Practical tip

In the BASIL trial, the bypass advantage appeared in those surviving more than 2 years.

2 more practical tips in the app.

Reference

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top